Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.
ADVANCED SEARCH
Log in
Top
The journal of nutrition, health & aging
Literature
1.
Rosenberg IH. Sarcopenia: Origins and clinical relevance. J Nutr 1997;127:9905–9915.
2.
Cruz-Jentoft AJ, Baeyens JP, Bauer JM, et al. Sarcopenia: European consensus on definition and diagnosis: Report of the European Working Group on sarcopenia in older people. Age Ageing 2010;39:412–423.PubMedPubMedCentral
3.
Fielding RA, Vellas B, Evans WJ, et al. Sarcopenia: An undiagnosed condition in older adults. Current consensus definition: Prevalence, etiology, and consequences. International Working Group on Sarcopenia. J Am Med Dir Assoc 2011;12:249–256.PubMed
4.
Anker SD, Morley JE, von Haehling S. Welcome to the ICD-10 code for sarcopenia. J Cachexia Sarcopenia Muscle 2016;7:512–514.PubMedPubMedCentral
5.
Chen L-K, Liu L-K, Wo J, et al. Sarcopenia in Asia: Consensus report of the Asian Working Group for Sarcopenia. J Am Med Dir Assoc 2014;15:95–101.PubMed
6.
Evans WJ, Hellerstein M, Orwoll E, et al. D3-Creatine dilution and the importance of accuracy in the assessment of skeletal muscle mass. J Cachexia Sarcopenia Muscle 2019;10:14–21.PubMedPubMedCentral
7.
Cawthon PM, Orwoll ES, Peters KE, et al; Osteoporotic Fractures in Men (MrOS) Study Research Group. Strong relation between muscle mass determined by D3-creatine dilution. Physical performance, and incidence of falls and mobility limitations in a prospective cohort of older men. J Gerontol A Biol Sci Med Sci 2019;74:844–852.PubMed
8.
McKee A, Morley JE, Matsumoto AM, Vinik A. Sarcopenia: An endocrine disorder?. Endocr Pract 2017;23:1140–1149.PubMed
9.
Baumgartner RN, Wayne SJ, Waters DL, et al. Sarcopenia obesity predicts instrumental activities of daily living disability in the elderly. Obes Res 2004;12:1995–2004.PubMed
10.
Morley JE. Pharmacologic options for the treatment of sarcopenia. Calcif Tissue Int 2016;98:319–333.PubMed
11.
Morley JE. Frailty and sarcopenia: The new geriatric giants. Rev Invest Clin 2016;68:59–67.PubMed
12.
Morley JE, Bauer JM. Editorial: The future of sarcopenia. Curr Opin Clin Nutr Metab Care 2019;22:1–3.PubMed
13.
Cruz-Jentoft AJ, Sayer AA. Sarcopenia. Lancet 2019;393-:2636–2646.PubMed
14.
Malmstrom TK, Morley JE. SARC-F: A simple questionnaire to rapidly diagnose sarcopenia. J Am Med Dir Assoc 2013;14:531–532.PubMed
15.
Cao L, Chen S, Zou C, et al. A pilot study of the SARC-F scale on screening sarcopenia and physical disability in the. Chinese older people. J Nutr Health Aging 2014;18:277–283.PubMed
16.
Woo J, Leung J, Morley JE. Validating the SARC-F: A suitable community screening tool for sarcopenia?. J Am Med Dir Assoc 2014;15:630–634.PubMed
17.
Malmstrom TK, Miller DK, Simonsick EM, et al. SARC-F: A symptom score to predict persons with sarcopenia at risk for poor functional outcomes. J Cachexia Sarcopenia Muscle 2016;7:28–36.PubMed
18.
Liccini A, Malmstrom TK. Frailty and sarcopenia as predictors of adverse health outcomes in persons with diabetes mellitus. J Am Med Dir Assoc 2016;17:846–851.PubMed
19.
Parra-Rodriguez L, Szlejf C, Garcia-Gonzalez AI, et al. Cross-cultural adaptation and validation of the Spanish-language version of the SARC-F to assess sarcopenia in Mexican Community-dwelling older adults. J Am Med Dir Assoc 2016;17:1142–1146.PubMed
20.
Ida S, Murata K, Nakadachi D, et al. Development of a Japanese version of the SARC-F for diabetic patients: An examination of reliability and validity. Aging Clin Exp Res 2017;29:935–942.PubMed
21.
Tanaka S, Kamiya K, Hamazaki N, et al. Utility of SARC-F for assessing physical function in elderly patients with cardiovascular disease. J Am Med Dir Assoc 2017;18:176–181.PubMed
22.
Rolland Y, Dupuy C, Abellan Van Kan G, et al. Sarcopenia screened by the SARC-F questionnaire and physical performances of elderly women: A cross-sectional study. J Am Med Dir Assoc 2017;18:848–852.PubMed
23.
Kemmler W, Sieber C, Freiberger E, von Stengel S. The SARC-F questionnaire: Diagnostic overlap with established sarcopenia definitions in older German men with sarcopenia. Gerontology 2017;63:411–416.PubMed
24.
Ida S, Nakai M, Ito S, et al. Association between sarcopenia and mild cognitive impairment using the Japanese version of the SARC-F in elderly patients with diabetes. J Am Med Dir Assoc 2017;18:809.e9–809.e13.
25.
Kim S, Kim M, Won CW. Validation of the Korean version of the SARC-F questionnaire to assess sarcopenia: Korean frailty and aging cohort study. J Am Med Dir Assoc 2018;19:40–45.e1.PubMed
26.
Lim WS, Tay L, Yeo A, et al. Modulating effect of contextual factors on factor structure and reliability of SARC-F. J AM Med Dir Assoc 2018;19:551–553.PubMed
27.
Ida S, Kaneko R, Murata K. SARC-F for screening of sarcopenia among older adults: A meta-analysis of screening test accuracy. J Am med Dir Assoc 2018;19:685–689.PubMed
28.
Yang M, Hu X, Xie L, et al. Comparing mini sarcopenia risk assessment with SARC-F for screening sarcopenia in community-dwelling older adults. J Am Med Dir Assoc 2019;20:53–57.PubMed
29.
Ida S, Murata K, Nakai M, et al. Relationship between sarcopenia and depression in older patients with diabetes: An investigation using the Japanese version of SARC-F. Geriatr Gerontol Int 2018;18:1318–1322.PubMed
30.
Ida S, Kojima Y, Hamaoka S, et al. Validity of Japanese version of SARC-F questionnaire in patients with chronic liver disease. J Gastroenterol Hepatol 2019;34:947–953.PubMed
31.
Bahat G, Yilmaz O, Kiliç C, et al. Performance of SARC-F in regard to sarcopenia definitions, muscle mass and functional measures. J Nutr Health Aging 2018;22:898–903.PubMed
32.
Su Y, Woo JW, Kwok TCY. The added value of SARC-F to prescreening using FRAX for hip fracture prevention in older community adults. J Am Med Dir Assoc 2019;20:83–89.PubMed
33.
34.
Dent E, Morley JE, Crruz-Jentoft AJ, et al. International Cliical Practice Guidelines for Sarcopenia (ICFSR): Screening, diagnosis and management. J Nutr Health Aging 2018;22:1148–1161.PubMed
35.
Barbosa-Silva TG, Menezes AM, Bielemann RM, et al; Grupo de Estudoes em Composição Corporal e Nutrição (COCONUT). Enhancing SARC-F; Improving sarcopenia screening in the clinical practice. J Am Med Dir Assoc 2016;17:1136–1141.PubMed
36.
Bahat G, Oren MM, Yilmaz O, et al. Comparing SARC-F with SARC-CalF to screen sarcopenia in community living older adults. J Nutr Health Aging 2018;22:1034–1038.PubMed
37.
Woo J, Yu R, Leung J. A 3-item SARC-F. J Am Med Dir Assoc 2018;19:223–228.PubMed
38.
Yang M, Hu X, Xie L, et al. SARC-F for sarcopenia screening in communitydwelling older adults: Are 3 items enough?. Medicine (Baltimore) 2018;97:e11726.
39.
Miller J, Wells L, Nwulu U, et al. Validated screening tools for the assessment of cachexia, sarcopenia, and malnutrition: A systematic review. Am J Clin Nutr 2018;108:1196–1208.PubMed
40.
Miller DK, Malmstrom TK, Andresen EM, et al. Development and validation of a short portable sarcopenia measure in the African American health project. J Gerontology: Med Sci 2009;64A:388–394.
41.
Rossi AP, Micciolo R, Rubele S, et al. Assessing the risk of sarcopenia in the elderly: The mini sarcopenia risk assessment (MSRA) questionnaire. J Nutr Helath Aging 2017;21:743–749.
42.
Yang M, Hu X, Xie L, et al. Comparing mini sarcopenia risk assessment with SARC-F for screening sarcopenia in community-dwelling older adults. J Am Med Dir Assoc 2019;20:53–57.PubMed
43.
Ishii S, Tomoki Tanaka, Shibasaki K, et al. Development of a simple screening test for sarcopenia in older adults. Geriatr Gerontol Int 2014;14 (Suppl 1):93–101.PubMed
44.
Cruz-Jentoft AJ, Bahat G, Bauer J, et al; Writing Group for the European Working Group on Sarcopenia in Older People 2 (EWGSP2), and the Extended Group for EWGSOP2. Sarcopenia: Revised European consensus on definition and diagnosis. Age Ageing 2019;48:16–31.PubMed
45.
Bauer J, Morley JE, Schols AMWJ et al. Sarcopenia: A time for action. J Cachexia, Sarcopenia and Muscle. 2019 (In press).
46.
Morley JE. Treatment of sarcopenia: The road to the future. J Cachexia Sarcopenia Muscle 2018;9:1196–1199.PubMed
47.
Beckwée D, Delaere A, Aelbrecht S, et al. Exercise interventions for the prevention and treatment of sarcopenia: A systematic umbrella review. J Nutr Health Aging 2019;23:494–502.PubMed
48.
Harada H, Kai H, Niiyama H, et al. Effectiveness of cardiac rehabilitation for prevention and treatment of sarcopenia in patients with cardiovascular disease - a retrospective cross-sectional analysis. J Nutr Health Aging 2017;21:449–456.PubMed
49.
Sáez de Asteasu ML, Martinez-Velilla N. Zamborn-Ferraresi F, et al. Physical exercise improves function in acutely hospitalized older patients: Secondary analysis of a randomized clinical trial. J Am Med Dir Assoc 2019;20:866–873.PubMed
50.
Bauer J, Biolo G, Cederholm T, et al. Evidence-based recommendations for optimal dietary protein intake in older people: A position paper from the PROT-AGE study group. J Am Med Dir Assoc 2013;14:542–559.PubMed
51.
Tieland M, Franssen R, Dullemeijer C, et al. The impact of dietary protein or amino acid supplementation on muscle mass and strength in elderly people: Individual participant data and meta-analysis of RCT’s. J Nutr Health Aging 2017;21:994–1001.PubMed
52.
Fielding RA, Travison TG, Kim DR, et al. Effect of structured physical activity and nutritional supplementation on physical function in mobility-limited older adults: Results from the VIVE2 randomized trial. J Nutr Health Aging 2017;21:936–942.PubMedPubMedCentral
53.
Osuka Y, Fujita S, Kitano N, et al. Effects of aerobic and resistance training combined with fortified milk on muscle mass, muscle strength, and physical performance in older adults: A randomized controlled trial. J Nutr Health Aging 2017;21:1349–1357.PubMed
54.
Oktaviana J, Zanker J, Vogrin S, Duque G. The effect of β-hydroxy-β-methylbutyrate (HMB) on Sarcopenia and functional frailty in older persons: A systematic review. J Nutr Health Aging 2019;23:145–150.PubMed
55.
Komar B, Schwingshackl L, Hoffmann G. Effects of leucine-rich protein supplements on anthropometric parameter and muscle strength in the elderly: A systematic review and meta-analysis. J Nutr Health Aging 2015;19:437–446.PubMed
56.
Merchant RA, van Dam RM, Tan LWL, et al. Vitamin D binding protein and vitamin D levels in multi-ethnic population. J Nutr Health Aging 2018;22:1060–1065.PubMed
57.
Morley JE. Editorial: Vitamin D: Does the emperor have no clothes?. J Nutr Health Aging 2019;23:316–317.PubMed
Metadata
Title
Screening for Sarcopenia
Authors
John E. Morley
A. M. Sanford
Publication date
01-11-2019
Publisher
Springer Paris
Keyword
Sarcopenia
Published in
The journal of nutrition, health & aging / Issue 9/2019
Print ISSN: 1279-7707
Electronic ISSN: 1760-4788
DOI
https://doi.org/10.1007/s12603-019-1259-x

Other articles of this Issue 9/2019

The journal of nutrition, health & aging 9/2019 Go to the issue

OriginalPaper

Allostatic Load as a Biological Substrate to Intrinsic Capacity: A Secondary Analysis of CRELES

OriginalPaper

Serum Stem Cell Factor Level Predicts Decline in Kidney Function in Healthy Aging Adults

OriginalPaper

Development and Validation of a Tool to Screen for Cognitive Frailty Among Community-Dwelling Elders

OriginalPaper

Obesity Paradox in Caucasian Seniors: Results of the PolSenior Study

OriginalPaper

Trace Element Levels in the Elders over 80 from the Hainan Province of China

OriginalPaper

Effect of a Resistance Training Program on Sarcopenia and Functionality of the Older Adults Living in a Nursing Home
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Reserve your place

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

Read more

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Pediatric Cardiology Video

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

Cardiopulmonary Comorbidity Video

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Valvular Heart Disease Video

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Heart Failure Video

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.

ACC 2024 Congress Coverage

Year in Review: Heart failure and cardiomyopathies

Heart Failure Video

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.

Watch now

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

16-04-2024 Type 2 Diabetes News

Incentivised to exercise

11-04-2024 Lifestyle Modifications News

New intervention for STEMI-related cardiogenic shock

10-04-2024 Myocardial Infarction News

» View more highlights on the ACC 2024 congress hub page

Image Credits